736 related articles for article (PubMed ID: 25681271)
21. Continuous oral administration of atorvastatin ameliorates brain damage after transient focal ischemia in rats.
Saito T; Nito C; Ueda M; Inaba T; Kamiya F; Muraga K; Katsura K; Katayama Y
Life Sci; 2014 Jan; 94(2):106-14. PubMed ID: 24333133
[TBL] [Abstract][Full Text] [Related]
22. The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats.
Zhao B; Zhao CZ; Zhang XY; Huang XQ; Shi WZ; Fang SH; Lu YB; Zhang WP; Xia Q; Wei EQ
Neuroscience; 2012 Jan; 202():42-57. PubMed ID: 22155652
[TBL] [Abstract][Full Text] [Related]
23. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
24. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.
Li DJ; Li YH; Yuan HB; Qu LF; Wang P
Metabolism; 2017 Mar; 68():31-42. PubMed ID: 28183451
[TBL] [Abstract][Full Text] [Related]
25. [Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats].
Zhang SH; Wei EQ; Zhu CY; Chen Z; Zhang SF
Yao Xue Xue Bao; 2004 Jan; 39(1):1-4. PubMed ID: 15127571
[TBL] [Abstract][Full Text] [Related]
26. Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke.
Ceprián M; Jiménez-Sánchez L; Vargas C; Barata L; Hind W; Martínez-Orgado J
Neuropharmacology; 2017 Apr; 116():151-159. PubMed ID: 28012949
[TBL] [Abstract][Full Text] [Related]
27. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
Nuñez-Figueredo Y; Ramírez-Sánchez J; Hansel G; Simões Pires EN; Merino N; Valdes O; Delgado-Hernández R; Parra AL; Ochoa-Rodríguez E; Verdecia-Reyes Y; Salbego C; Costa SL; Souza DO; Pardo-Andreu GL
Neuropharmacology; 2014 Oct; 85():517-27. PubMed ID: 24953828
[TBL] [Abstract][Full Text] [Related]
28. Pre-ischemic treadmill training alleviates brain damage via GLT-1-mediated signal pathway after ischemic stroke in rats.
Wang X; Zhang M; Yang SD; Li WB; Ren SQ; Zhang J; Zhang F
Neuroscience; 2014 Aug; 274():393-402. PubMed ID: 24907601
[TBL] [Abstract][Full Text] [Related]
29. Chloral Hydrate Preconditioning Protects Against Ischemic Stroke via Upregulating Annexin A1.
Liu JH; Feng D; Zhang YF; Shang Y; Wu Y; Li XF; Pei L
CNS Neurosci Ther; 2015 Sep; 21(9):718-26. PubMed ID: 26205642
[TBL] [Abstract][Full Text] [Related]
30. Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice.
Yu GL; Wei EQ; Wang ML; Zhang WP; Zhang SH; Weng JQ; Chu LS; Fang SH; Zhou Y; Chen Z; Zhang Q; Zhang LH
Brain Res; 2005 Aug; 1053(1-2):116-25. PubMed ID: 16051204
[TBL] [Abstract][Full Text] [Related]
31. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
Zawadzka M; Kaminska B
Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
[TBL] [Abstract][Full Text] [Related]
32. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
33. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
34. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
35. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.
Yang C; Zhang X; Fan H; Liu Y
Brain Res; 2009 Jul; 1282():133-41. PubMed ID: 19445907
[TBL] [Abstract][Full Text] [Related]
36. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window.
Yu YM; Kim JB; Lee KW; Kim SY; Han PL; Lee JK
Stroke; 2005 Oct; 36(10):2238-43. PubMed ID: 16141417
[TBL] [Abstract][Full Text] [Related]
38. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
39. Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia.
Fang SH; Zhou Y; Chu LS; Zhang WP; Wang ML; Yu GL; Peng F; Wei EQ
Neurosci Lett; 2007 Jan; 412(1):78-83. PubMed ID: 17196746
[TBL] [Abstract][Full Text] [Related]
40. [Protective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in mice].
Zeng LH; Zhang WP; Wang RD; Wang PL; Wei EQ
Yao Xue Xue Bao; 2001 Feb; 36(2):148-50. PubMed ID: 12579886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
